$119.79
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Lear
LEANYSE
Lear (NYSE:LEA) Stock, Analyst Ratings, Price Targets, Forecasts
Lear Corp has a consensus price target of $162.3 based on the ratings of 21 analysts. The high is $215 issued by Credit Suisse on August 10, 2021. The low is $127 issued by Citigroup on July 12, 2024. The 3 most-recent analyst ratings were released by B of A Securities, JP Morgan, and Barclays on July 22, 2024, July 22, 2024, and July 16, 2024, respectively. With an average price target of $168.67 between B of A Securities, JP Morgan, and Barclays, there's an implied 40.80% upside for Lear Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B of A Securities
JP Morgan
Barclays
Evercore ISI Group
Citigroup
1calculated from analyst ratings
Analyst Ratings for Lear
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | 54.44% | B of A Securities | John Murphy | $205 → $185 | Maintains | Buy | Get Alert |
| 07/22/2024 | Buy Now | 38.58% | JP Morgan | Ryan Brinkman | $179 → $166 | Maintains | Overweight | Get Alert |
| 07/16/2024 | Buy Now | 29.39% | Barclays | Dan Levy | $165 → $155 | Maintains | Overweight | Get Alert |
| 07/15/2024 | Buy Now | 21.05% | Evercore ISI Group | Chris McNally | $155 → $145 | Maintains | In-Line | Get Alert |
| 07/12/2024 | Buy Now | 6.02% | Citigroup | Itay Michaeli | $141 → $127 | Maintains | Neutral | Get Alert |
| 07/10/2024 | Buy Now | 6.85% | UBS | Joseph Spak | $136 → $128 | Maintains | Neutral | Get Alert |
| 06/25/2024 | Buy Now | 10.19% | Wells Fargo | Colin Langan | $139 → $132 | Maintains | Equal-Weight | Get Alert |
| 06/13/2024 | Buy Now | 13.53% | UBS | Joseph Spak | $142 → $136 | Maintains | Neutral | Get Alert |
| 05/10/2024 | Buy Now | 33.57% | Morgan Stanley | Adam Jonas | $150 → $160 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/02/2024 | Buy Now | 37.74% | Barclays | Dan Levy | $175 → $165 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | 17.71% | Citigroup | Itay Michaeli | $145 → $141 | Maintains | Neutral | Get Alert |
| 05/01/2024 | Buy Now | 16.04% | Wells Fargo | Colin Langan | $134 → $139 | Maintains | Equal-Weight | Get Alert |
| 05/01/2024 | Buy Now | 18.54% | UBS | Colin Langan | $146 → $142 | Maintains | Neutral | Get Alert |
| 04/22/2024 | Buy Now | 49.43% | JP Morgan | Ryan Brinkman | $177 → $179 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 46.09% | Barclays | Dan Levy | $170 → $175 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 25.22% | Morgan Stanley | Adam Jonas | $140 → $150 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | Buy Now | 11.86% | Wells Fargo | Colin Langan | $130 → $134 | Maintains | Equal-Weight | Get Alert |
| 01/25/2024 | Buy Now | 49.43% | JP Morgan | Ryan Brinkman | $195 → $179 | Maintains | Overweight | Get Alert |
| 01/24/2024 | Buy Now | 41.92% | Barclays | Brian Johnson | $175 → $170 | Maintains | Overweight | Get Alert |
| 01/02/2024 | Buy Now | 66.96% | Benchmark | Michael Ward | $188 → $200 | Maintains | Buy | Get Alert |
| 10/30/2023 | Buy Now | 56.94% | Benchmark | Michael Ward | → $188 | Reiterates | Buy → Buy | Get Alert |
| 10/30/2023 | Buy Now | 46.09% | Barclays | Brian Johnson | $177 → $175 | Maintains | Overweight | Get Alert |
| 10/12/2023 | Buy Now | — | Barclays | Brian Johnson | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/11/2023 | Buy Now | 26.89% | Citigroup | Itay Michaeli | $158 → $152 | Maintains | Neutral | Get Alert |
| 10/10/2023 | Buy Now | 21.05% | UBS | Colin Langan | $150 → $145 | Maintains | Neutral | Get Alert |
| 10/03/2023 | Buy Now | 18.54% | Wells Fargo | Colin Langan | $164 → $142 | Maintains | Equal-Weight | Get Alert |
| 09/13/2023 | Buy Now | 25.22% | UBS | Colin Langan | → $150 | Initiates | → Neutral | Get Alert |
| 08/07/2023 | Buy Now | 56.94% | Benchmark | Michael Ward | $182 → $188 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 50.26% | Argus Research | Jim Corridore | $150 → $180 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 51.93% | Benchmark | Michael Ward | $170 → $182 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 31.9% | Citigroup | Itay Michaeli | $152 → $158 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | 36.91% | Wells Fargo | Colin Langan | $144 → $164 | Maintains | Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | 49.43% | JP Morgan | Ryan Brinkman | $169 → $179 | Maintains | Overweight | Get Alert |
| 07/18/2023 | Buy Now | 26.89% | Citigroup | Itay Michaeli | $140 → $152 | Maintains | Neutral | Get Alert |
| 07/11/2023 | Buy Now | 37.74% | Barclays | Brian Johnson | $150 → $165 | Maintains | Equal-Weight | Get Alert |
| 07/10/2023 | Buy Now | 20.21% | Wells Fargo | Colin Langan | $141 → $144 | Maintains | Equal-Weight | Get Alert |
| 06/28/2023 | Buy Now | 22.71% | Deutsche Bank | Emmanuel Rosner | $137 → $147 | Maintains | Hold | Get Alert |
| 06/28/2023 | Buy Now | 51.93% | Benchmark | Michael Ward | $170 → $182 | Maintains | Buy | Get Alert |
| 06/28/2023 | Buy Now | 16.87% | Morgan Stanley | Adam Jonas | $135 → $140 | Maintains | Equal-Weight | Get Alert |
| 06/01/2023 | Buy Now | — | Exane BNP Paribas | James Picariello | — | Upgrade | Neutral → Outperform | Get Alert |
| 05/01/2023 | Buy Now | 16.87% | Citigroup | Itay Michaeli | $143 → $140 | Maintains | Neutral | Get Alert |
| 05/01/2023 | Buy Now | 25.22% | Barclays | Brian Johnson | $155 → $150 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 14.37% | Deutsche Bank | Emmanuel Rosner | $136 → $137 | Maintains | Hold | Get Alert |
| 04/28/2023 | Buy Now | 11.03% | Wells Fargo | Colin Langan | $141 → $133 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | Buy Now | 17.71% | Wells Fargo | Colin Langan | $146 → $141 | Maintains | Equal-Weight | Get Alert |
| 03/22/2023 | Buy Now | 12.7% | Morgan Stanley | Adam Jonas | $133 → $135 | Maintains | Equal-Weight | Get Alert |
| 02/07/2023 | Buy Now | 19.38% | Citigroup | Itay Michaeli | $146 → $143 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | 21.05% | Evercore ISI Group | Chris McNally | $150 → $145 | Downgrade | Outperform → In-Line | Get Alert |
| 02/03/2023 | Buy Now | 44.42% | Cowen & Co. | Jeffrey Osborne | $165 → $173 | Maintains | Outperform | Get Alert |
| 02/03/2023 | Buy Now | 41.92% | Benchmark | Michael Ward | → $170 | Reiterates | → Buy | Get Alert |
| 01/20/2023 | Buy Now | 41.92% | Benchmark | Michael Ward | $162 → $170 | Maintains | Buy | Get Alert |
| 01/17/2023 | Buy Now | 16.87% | Wells Fargo | Colin Langan | $139 → $140 | Maintains | Equal-Weight | Get Alert |
| 01/13/2023 | Buy Now | 21.88% | Citigroup | Itay Michaeli | $138 → $146 | Maintains | Neutral | Get Alert |
| 12/14/2022 | Buy Now | 16.04% | Wells Fargo | Colin Langan | $149 → $139 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/02/2022 | Buy Now | 24.38% | Wells Fargo | Colin Langan | $157 → $149 | Maintains | Overweight | Get Alert |
| 11/02/2022 | Buy Now | 15.2% | Citigroup | Itay Michaeli | $137 → $138 | Maintains | Neutral | Get Alert |
| 11/02/2022 | Buy Now | 14.37% | RBC Capital | Joseph Spak | $142 → $137 | Maintains | Sector Perform | Get Alert |
| 11/02/2022 | Buy Now | 11.03% | Morgan Stanley | Adam Jonas | $140 → $133 | Maintains | Equal-Weight | Get Alert |
| 09/29/2022 | Buy Now | 18.54% | RBC Capital | Joseph Spak | $158 → $142 | Maintains | Sector Perform | Get Alert |
| 09/28/2022 | Buy Now | 14.37% | Citigroup | Itay Michaeli | $162 → $137 | Maintains | Neutral | Get Alert |
| 09/09/2022 | Buy Now | 54.44% | B of A Securities | John Murphy | $195 → $185 | Maintains | Buy | Get Alert |
| 08/04/2022 | Buy Now | 16.87% | Morgan Stanley | Adam Jonas | $139 → $140 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 31.9% | RBC Capital | Joseph Spak | $144 → $158 | Maintains | Sector Perform | Get Alert |
| 08/03/2022 | Buy Now | 45.25% | Goldman Sachs | Mark Delaney | $158 → $174 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | 44.42% | Wells Fargo | Colin Langan | $170 → $173 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | 16.04% | Morgan Stanley | Adam Jonas | $144 → $139 | Maintains | Equal-Weight | Get Alert |
| 07/11/2022 | Buy Now | 16.87% | Exane BNP Paribas | James Picariello | → $140 | Upgrade | Underperform → Neutral | Get Alert |
| 07/11/2022 | Buy Now | 41.92% | Wells Fargo | Colin Langan | $180 → $170 | Maintains | Overweight | Get Alert |
| 06/07/2022 | Buy Now | 50.26% | Wells Fargo | Colin Langan | → $180 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 06/02/2022 | Buy Now | 20.21% | Morgan Stanley | Adam Jonas | $160 → $144 | Maintains | Equal-Weight | Get Alert |
| 05/04/2022 | Buy Now | 46.09% | Benchmark | Michael Ward | $206 → $175 | Maintains | Buy | Get Alert |
| 05/04/2022 | Buy Now | 26.05% | RBC Capital | Joseph Spak | $163 → $151 | Maintains | Sector Perform | Get Alert |
| 04/21/2022 | Buy Now | 31.06% | Deutsche Bank | Emmanuel Rosner | $197 → $157 | Maintains | Hold | Get Alert |
| 04/11/2022 | Buy Now | — | Exane BNP Paribas | James Picariello | — | Initiates | → Underperform | Get Alert |
| 04/07/2022 | Buy Now | 10.19% | Barclays | Brian Johnson | $161 → $132 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | Buy Now | 33.57% | Morgan Stanley | Adam Jonas | $175 → $160 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | Buy Now | 62.78% | B of A Securities | John Murphy | → $195 | Upgrade | Underperform → Buy | Get Alert |
| 04/01/2022 | Buy Now | 31.9% | Wells Fargo | Colin Langan | $174 → $158 | Maintains | Equal-Weight | Get Alert |
| 03/22/2022 | Buy Now | 41.92% | Goldman Sachs | Mark Delaney | $189 → $170 | Maintains | Buy | Get Alert |
| 02/28/2022 | Buy Now | 46.09% | Morgan Stanley | Adam Jonas | $200 → $175 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/09/2022 | Buy Now | 64.45% | Deutsche Bank | Emmanuel Rosner | $204 → $197 | Maintains | Hold | Get Alert |
| 02/09/2022 | Buy Now | 45.25% | Wells Fargo | Colin Langan | $195 → $174 | Maintains | Equal-Weight | Get Alert |
| 12/16/2021 | Buy Now | 36.07% | Barclays | — | — | Maintains | Equal-Weight | Get Alert |
| 12/16/2021 | Buy Now | 62.78% | Wells Fargo | Colin Langan | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/14/2021 | Buy Now | 66.96% | Morgan Stanley | Adam Jonas | — | Maintains | Overweight | Get Alert |
| 11/03/2021 | Buy Now | 59.45% | Wells Fargo | Colin Langan | — | Maintains | Overweight | Get Alert |
| 11/03/2021 | Buy Now | 46.92% | RBC Capital | — | — | Downgrade | Outperform → Sector Perform | Get Alert |
| 10/12/2021 | Buy Now | 83.65% | Evercore ISI Group | Chris McNally | — | Upgrade | In-Line → Outperform | Get Alert |
| 10/11/2021 | Buy Now | 29.39% | Barclays | Brian Johnson | — | Maintains | Equal-Weight | Get Alert |
| 10/05/2021 | Buy Now | 46.92% | Wells Fargo | Colin Langan | — | Maintains | Overweight | Get Alert |
| 09/27/2021 | Buy Now | 61.12% | Goldman Sachs | Mark Delaney | — | Maintains | Buy | Get Alert |
| 09/20/2021 | Buy Now | 42.75% | Jefferies | David Kelley | — | Downgrade | Buy → Hold | Get Alert |
| 09/16/2021 | Buy Now | — | B of A Securities | John Murphy | — | Downgrade | Neutral → Underperform | Get Alert |
| 09/10/2021 | Buy Now | 66.12% | Wells Fargo | Colin Langan | — | Maintains | Overweight | Get Alert |
| 08/10/2021 | Buy Now | 65.29% | Benchmark | Michael Ward | — | Maintains | Buy | Get Alert |
| 08/10/2021 | Buy Now | 79.48% | Credit Suisse | Dan Levy | — | Maintains | Outperform | Get Alert |
| 08/09/2021 | Buy Now | 75.31% | RBC Capital | Joseph Spak | — | Maintains | Outperform | Get Alert |
| 08/09/2021 | Buy Now | 69.46% | Wells Fargo | Colin Langan | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Lear (LEA) stock?
The latest price target for Lear (NYSE:LEA) was reported by B of A Securities on July 22, 2024. The analyst firm set a price target for $185.00 expecting LEA to rise to within 12 months (a possible 54.44% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lear (LEA)?
The latest analyst rating for Lear (NYSE:LEA) was provided by B of A Securities, and Lear maintained their buy rating.
When was the last upgrade for Lear (LEA)?
The last upgrade for Lear Corp happened on May 10, 2024 when Morgan Stanley raised their price target to $160. Morgan Stanley previously had an equal-weight for Lear Corp.
When was the last downgrade for Lear (LEA)?
The last downgrade for Lear Corp happened on February 6, 2023 when Evercore ISI Group changed their price target from $150 to $145 for Lear Corp.
When is the next analyst rating going to be posted or updated for Lear (LEA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lear, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lear was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Lear (LEA) correct?
While ratings are subjective and will change, the latest Lear (LEA) rating was a maintained with a price target of $205.00 to $185.00. The current price Lear (LEA) is trading at is $119.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.